These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38770706)

  • 1. Assessment of the effect of gabapentin on blood pressure in cats with and without chronic kidney disease.
    Quimby JM; Jones SE; Saffire A; Brusach KK; Kurdziel K; George Z; Paschall RE; Aarnes TK
    J Feline Med Surg; 2024 May; 26(5):1098612X241240326. PubMed ID: 38770706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gabapentin on ambulatory, direct, systemic arterial blood pressure in apparently healthy cats in the at-home and in-clinic environments.
    De Lombaert MC; Lourenço BN; Coleman AE; Arne AM; Berghaus RD; Schmiedt CW
    J Feline Med Surg; 2023 Aug; 25(8):1098612X231188770. PubMed ID: 37594245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of gabapentin in cats with chronic kidney disease.
    Quimby JM; Lorbach SK; Saffire A; Kennedy A; Wittenburg LA; Aarnes TK; Creighton KJ; Jones SE; Paschall RE; King EM; Bruner CE; Wallinger JN; van Haaften KA
    J Feline Med Surg; 2022 Dec; 24(12):1260-1266. PubMed ID: 35195476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of audible static on blood pressure measurement by Doppler ultrasonic sphygmomanometry in cats.
    Uematsu S; Summers S; Keys D; Quimby J
    J Feline Med Surg; 2023 Sep; 25(9):1098612X231197084. PubMed ID: 37751181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Quimby JM; Brock WT; Moses K; Bolotin D; Patricelli K
    J Feline Med Surg; 2015 Aug; 17(8):692-7. PubMed ID: 25336450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.
    Takenaka M; Iio A; Sato R; Sakamoto T; Kurumatani H;
    J Vet Intern Med; 2018 Jan; 32(1):236-248. PubMed ID: 29131397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS; Roof CJ; Sanderson MW; Grauer GF
    J Vet Intern Med; 2014; 28(4):1221-8. PubMed ID: 24773179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats.
    Guedes AGP; Meadows JM; Pypendop BH; Johnson EG; Zaffarano B
    J Am Vet Med Assoc; 2018 Sep; 253(5):579-585. PubMed ID: 30110208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose meloxicam in cats with chronic kidney disease.
    KuKanich K; George C; Roush JK; Sharp S; Farace G; Yerramilli M; Peterson S; Grauer GF
    J Feline Med Surg; 2021 Feb; 23(2):138-148. PubMed ID: 32594827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease.
    Gowan RA; Lingard AE; Johnston L; Stansen W; Brown SA; Malik R
    J Feline Med Surg; 2011 Oct; 13(10):752-61. PubMed ID: 21906984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appetite-stimulating effects of once-daily omeprazole in cats with chronic kidney disease: Double-blind, placebo-controlled, randomized, crossover trial.
    Spencer A; Quimby JM; Price JM; MacLane S; Hillsman S; Secoura P; Steiner JM; Katherine Tolbert M
    J Vet Intern Med; 2021 Nov; 35(6):2705-2712. PubMed ID: 34590746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplementation of vitamin E as an addition to a commercial renal diet does not prolong survival of cats with chronic kidney disease.
    Krofič Žel M; Tavčar Kalcher G; Vovk T; Žegura B; Lusa L; Tozon N; Nemec Svete A
    BMC Vet Res; 2024 Jul; 20(1):308. PubMed ID: 38987749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial.
    Quimby JM; Lunn KF
    Vet J; 2013 Sep; 197(3):651-5. PubMed ID: 23838205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between indirect blood pressure and various stages of chronic kidney disease in cats.
    Hori Y; Heishima Y; Yamashita Y; Isayama N; Kanno N; Nakamura K; Iguchi M; Ibaragi T; Onodera H; Aramaki Y; Hirakawa A; Yamano S; Katagi M; Kitade A; Sawada T
    J Vet Med Sci; 2018 Mar; 80(3):447-452. PubMed ID: 29311521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination.
    van Haaften KA; Forsythe LRE; Stelow EA; Bain MJ
    J Am Vet Med Assoc; 2017 Nov; 251(10):1175-1181. PubMed ID: 29099247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial.
    Pankratz KE; Ferris KK; Griffith EH; Sherman BL
    J Feline Med Surg; 2018 Jun; 20(6):535-543. PubMed ID: 28718700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the stress markers cortisol and glucose before and during intradermal testing in cats after single administration of pre-appointment gabapentin.
    Hudec CP; Griffin CE
    J Feline Med Surg; 2020 Feb; 22(2):138-145. PubMed ID: 30982420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.